IV immunoglobulin confounds JC virus antibody serostatus determination. - Wikidata - awgldk - TriplyDB

IV immunoglobulin confounds JC virus antibody serostatus determination.

IV immunoglobulin confounds JC virus antibody serostatus determination.

http://www.wikidata.org/entity/Q34376445

about

A meditation on medications, among other things Stability and predictive value of anti-JCV antibody index in multiple sclerosis: A 6-year longitudinal study.CD62L is not a reliable biomarker for predicting PML risk in natalizumab-treated R-MS patients.Therapy with natalizumab is associated with high JCV seroconversion and rising JCV index values.The clinical utility of JC virus antibody index measurements in the context of progressive multifocal leukoencephalopathy.

P2860

Q34376438-EA15C634-D69B-49CF-9428-17F3077CDDE0 Q36314901-764FE3FB-4963-4E2B-8735-D25B326B88E0 Q36645170-1BC741A1-6B2C-49FE-A2C1-2A61B9EA6D63 Q40928069-5BE2EC1D-D5C3-4DF4-8EC9-BF7F8945CF3A Q45325710-CCB704C8-B63C-4F2C-8751-C2541D789224

P2860

IV immunoglobulin confounds JC virus antibody serostatus determination.

http://www.wikidata.org/entity/Q34376445

description

2014 nî lūn-bûn

@nan

2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

IV immunoglobulin confounds JC virus antibody serostatus determination.

@ast

IV immunoglobulin confounds JC virus antibody serostatus determination.

@en

IV immunoglobulin confounds JC virus antibody serostatus determination.

@nl

type

label

IV immunoglobulin confounds JC virus antibody serostatus determination.

@ast

IV immunoglobulin confounds JC virus antibody serostatus determination.

@en

IV immunoglobulin confounds JC virus antibody serostatus determination.

@nl

prefLabel

IV immunoglobulin confounds JC virus antibody serostatus determination.

@ast

IV immunoglobulin confounds JC virus antibody serostatus determination.

@en

IV immunoglobulin confounds JC virus antibody serostatus determination.

@nl

P1433

Q34376445-CC0B556B-DA93-4FEC-9C8E-A5243E58548D

P1476

Q34376445-25635D5E-F16B-4B39-861B-CC1ED92D94EB

P2093

Q34376445-4B6EEDA2-52A1-4C45-8888-75DD7F953E92

Q34376445-7A3A0904-99C3-4EDB-B1BF-8C16EA67F4C3

Q34376445-A2473E15-73EE-4316-8EB6-6F89EA47B6E7

Q34376445-B655D19D-A2DB-4E1A-A36A-4E19F548CA15

Q34376445-E2319DD5-5278-470B-86CE-CF9710AD8ED3

Q34376445-F3A94AFB-FDE4-4714-AB80-C79349A61C7C

Q34376445-FEE1610E-7441-41ED-A656-411871E7880A

P2860

Q34376445-0073D381-6958-4B4B-A833-14FBE7026D03

Q34376445-1144428B-555F-4BC1-B392-C2815513EA58

Q34376445-178C6D27-9E74-4498-82D8-3014FDCAA183

Q34376445-2B5EFB39-17E8-41BA-B148-7A261A305656

Q34376445-484502BA-27B8-424F-8F56-DF5EB148A16E

Q34376445-5D5788F6-1EB2-4EE7-9B64-2F47612C9084

Q34376445-67B9FCC5-6E32-48BA-A1FC-941D361AA3A6

Q34376445-79C53640-A344-47AC-9487-2240859B0253

Q34376445-A3628F13-E15F-4452-A424-9FCA80D3C96F

Q34376445-A4751006-E6C1-4F31-97C0-72B9EF7FA225

P304

Q34376445-BEAE5722-2F27-4EC5-B24A-2A32643DD519

P31

Q34376445-9AF9D2DD-B194-4650-A73D-26C093C161CC

P356

Q34376445-47EA57F5-FA92-4B79-965D-5EAC0F7AD83D

P433

Q34376445-3053E038-BD2A-465A-840B-97EFDC50589C

P478

Q34376445-6A2AFE5F-C9B3-49A2-8FA2-DD1FCB49342C

P50

Q34376445-A92C4F5A-2435-42F3-A027-FEF754CB3FEF

P577

Q34376445-27359C50-48D4-4902-9052-620FC267E5EE

P698

Q34376445-F205ABCC-24B3-4C5C-9748-D4B0A2E24963

P932

Q34376445-DEFF1AE3-3A1F-4328-A832-EA4CFEF60D3A

P356

NXI.0000000000000029

P1433

Neurology(R) neuroimmunology & neuroinflammation

P1476

IV immunoglobulin confounds JC virus antibody serostatus determination.

@en

P2093

Eric Chamot

http://www.w3.org/2001/XMLSchema#string

Geoffrey Kuesters

http://www.w3.org/2001/XMLSchema#string

Joseph Herbert

http://www.w3.org/2001/XMLSchema#string

Kim Dontas

http://www.w3.org/2001/XMLSchema#string

Mary Yarussi

http://www.w3.org/2001/XMLSchema#string

Meena Subramanyam

http://www.w3.org/2001/XMLSchema#string

Mirza Omari

http://www.w3.org/2001/XMLSchema#string

P2860

Passively acquired treponemal antibody from intravenous immunoglobulin therapy in a pregnant patient.

Misleading hepatitis B test results due to intravenous immunoglobulin administration: implications for a clinical trial of rituximab in immune thrombocytopenia.

Risk of natalizumab-associated progressive multifocal leukoencephalopathy.

EFNS guidelines for the use of intravenous immunoglobulin in treatment of neurological diseases: EFNS task force on the use of intravenous immunoglobulin in treatment of neurological diseases.

False-positive human T-lymphotropic virus serology after intravenous immunoglobulin transfusion.

Pharmacokinetics of cytomegalovirus specific IgG antibody following intravenous immunoglobulin in bone marrow transplant patients.

Anti-JC virus antibodies in a large German natalizumab-treated multiple sclerosis cohort.

Immunoglobulin preparations from hepatitis C antibody-positive plasma donors: influence on diagnosis and risk of infection in heart transplant recipients.

Seroconversion for hepatitis C virus antibody in bone marrow recipients treated with immune globulin.

Hepatitis C virus antibody seroconversion in bone marrow transplant recipients treated with immune globulin: the impact of the problem.

P304

e29

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1212/NXI.0000000000000029

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

1

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-09-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25340081

http://www.w3.org/2001/XMLSchema#string

P932

4204227

http://www.w3.org/2001/XMLSchema#string